Eltek .(US:ELTK) Prnewswireยท2025-08-14 11:30Core Insights - Eltek Ltd. reported a 20% increase in revenue for Q2 2025, reaching $12.5 million compared to $10.5 million in Q2 2024, driven by strong performance in defense and medical segments [2][5] - The gross margin expanded significantly to 24.1%, up from 15.6% in the same quarter last year, reflecting operational improvements and a favorable product mix [2][6] - Operating income surged by 259% to $1.5 million, more than tripling from $0.4 million in Q2 2024, indicating robust operational efficiency [2][6] Financial Performance - Revenues for the first six months of 2025 totaled $25.3 million, a 14% increase from $22.2 million in the same period of 2024 [2][10] - Gross profit for the first half of 2025 was $5.2 million, representing 21% of revenues, compared to $4.9 million (22% of revenues) in the first half of 2024 [10][11] - Net income for Q2 2025 was $0.4 million or $0.05 per diluted share, down from $0.8 million or $0.11 per diluted share in Q2 2024 [7][20] Operational Developments - The company is committed to expanding production capacity, with successful installation of new equipment and ongoing construction of new coating lines [3][4] - Staffing has increased by approximately 10% since January to meet growing demand while maintaining lead times [4] - A non-cash financial expense of $1.0 million was incurred due to the appreciation of the Israeli shekel, prompting a proactive update to the pricing model to protect margins [5][7] Non-GAAP Financial Metrics - EBITDA for Q2 2025 was $2.0 million, or 15.6% of revenues, compared to $0.8 million (7.6% of revenues) in Q2 2024 [9][22] - For the first six months of 2025, non-GAAP EBITDA was $3.1 million (12% of revenues), slightly up from $2.9 million (13% of revenues) in the same period of 2024 [12][22]